Study #2022-0769
TriNav Infusion System for the Evaluation of Fidelity between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning (Tri-FY90)
MD Anderson Study Status
Enrolling
Treatment Agent
Diagnostic Test: Angiogram
Description
To learn if using the TriNav Infusion System (TriNav catheter) for the injection of the surrogate/test dose during the planning part of the radioembolization procedure and your actual treatment with the radioactive microspheres match each other better than the standard catheter.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Liver Cancer
Study phase:
Not applicable
Physician name:
Armeen Mahvash
Department:
Interventional Radiology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.